Application

Jun 04, 2025

May 22, 2022

The InVivoPro Anti-Mouse CD4 in vivo antibody, Clone GK1.5 is a cornerstone tool in preclinical immunology research, enabling precise depletion of CD4⁺ T cells to study their role in immune responses. Developed by BioXCell, this monoclonal antibody target

May 22, 2022

The InVivoPro Anti-Mouse PD-L1 (B7-H1, CD274) in vivo antibody, Clone 10F.9G2 is a cutting-edge tool for preclinical cancer immunotherapy research, designed to block the PD-1/PD-L1 immune checkpoint pathway with high specificity and efficacy. Developed by

May 22, 2022

The InVivoPro Anti-Mouse PD-1 (CD279) in vivo antibody, Clone RMP1-14 has emerged as a pivotal tool in preclinical cancer immunotherapy research, enabling robust blockade of the PD-1/PD-L1 immune checkpoint pathway. This high-specificity monoclonal antibo